Evidence map›Paper›PMID 35665253›Full record

ReviewFrontiers in cardiovascular medicine2022

Role of Catestatin in the Cardiovascular System and Metabolic Disorders.

Ewa Zalewska, Piotr Kmieć, Krzysztof Sworczak

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cardiovascular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Serum Catestatin Level as a Novel Biomarker of Oral Lichen Planus.Medical sciences (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Catestatin in Cardiovascular Diseases.International journal of molecular sciences · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Role of Catestatin in Preeclampsia.International journal of molecular sciences · 2024
    Review
  11. Article
  12. Neurohumoral Activation in Heart Failure.International journal of molecular sciences · 2023
    Review
  13. Sympathetic Nervous System and Atherosclerosis.International journal of molecular sciences · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ewa ZalewskaDepartment of Endocrinology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland.
Piotr KmiećDepartment of Endocrinology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland.
Krzysztof SworczakDepartment of Endocrinology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland.
Gdańsk Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Catestatin is a multifunctional peptide that is involved in the regulation of the cardiovascular and immune systems as well as metabolic homeostatis. It mitigates detrimental, excessive activity of the sympathetic nervous system by inhibiting catecholamine secretion. Based on

Indexed as

cardiovascular systemcatestatincoronary artery diseaseheart failurehypertensionimmunometabolismmetabolic disorder

Identifiers

PMID35665253
PMCPMC9160393
OpenAlexW4280629561

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.